Check out our news archive below to learn more about what’s happening in Duke Psychiatry & Behavioral Sciences!
Helping people — whether it be at a makeshift COVID-19 field hospital in New York City or through the Healthcare for the Homeless volunteer psychiatry clinic in Durham — is what drives internal medicine-psychiatry resident Colin Smith, MD, in his work as a physician.
Oxytocin, a naturally occurring hormone that acts as a chemical messenger in the brain, showed no evidence of helping children with autism gain social skills, according to a large national study published in the New England Journal of Medicine.
Beth Glascock, MPA, joined the Department of Psychiatry & Behavioral Sciences as our new Vice Chair for Administration and Finance on October 1.
In this TEDx Talk, Duke clinical psychology intern Briana Brownlow discusses the unique ways Black Americans often cope with chronic racial stress and how this coping strategy may serve as a potential mechanism through which racism impacts their physical and mental health.
Kafui Dzirasa, MD, PhD, the K. Ranga Rama Krishnan Associate Professor in the Department of Psychiatry & Behavioral Sciences, has been named a Howard Hughes Medical Institute (HHMI) investigator.
Duke Psychiatry's Dr. Jason Cho says we need to be intentional about creating opportunities to be quiet and still, especially in the Zoom era. Check out the great tips in this article for both relaxing and energizing ourselves.
In this Q&A, Duke Psychiatry's Shelley A. Holmer, MD, explains how the new behavioral health center meets a critical population health need in the region, the unique benefits to patients, and how providers can best refer their patients for assessment and treatment.
While marijuana use may impact some genes linked to autism in men’s sperm, abstaining from cannabis consumption over time may significantly lower many of those effects, according to a study by Duke Health researchers.
A team co-led by David Goldston, PhD, Associate Professor of Psychiatry and Behavioral Sciences at Duke University, and Joan Asarnow, PhD, Professor of Psychiatry and Biobehavioral Sciences at UCLA, has been approved for a $13 million award by the Patient-Centered Outcomes Research Institute.
A suicide screening tool developed by researchers from Duke Psychiatry and the Department of Veterans Affairs is far more accurate at identifying patients at risk for attempting suicide than current clinical assessments, which often have poor accuracy rates that can lead to the loss of life.